By Kevin Closson, M.S., MBA, Nerac Analyst,
Originally Published: October 14th, 2015
Faced with continuing business uncertainty, intellectual property professionals across a wide variety of industries are seeking ways to gain competitive advantage for their firms while simultaneously capitalizing on their companies’ own R&D investments.
This article takes a look at a recent survey of IP professionals which reveals the paths they are taking in order to address these two goals.
- 58By Nerac IP Analysts Originally published July 28, 2020 Changing industry demands and new business challenges are also offering unprecedented opportunity. Whether it’s sudden disruption to your supply chain, rapidly evolving market demands, disruptive technologies, new strategic partnering options or all of these things, you need the ability to pivot quickly and efficiently. You need…
- 57Nerac was selected as the primary go-to resource for IP vetting services including freedom to operate, invalidity and IP landscape studies. Have a question for Kevin? Want to give Nerac a shot? Let us know!
- 50Introduction The global market for biotechnology represents a large and complex amalgamation of different products that touches many different industry segments. In the healthcare industry alone, biologics represent a greater than $125 billion global market, and biosimilars legislation in the US and EU has spawned new generic biologics markets that will continue to grow. In…